EirGenix, Inc. Enters Into Global License Agreement for the Co...
NEW TAIPEI CITY, Taiwan, April 30, 2019 /PRNewswire-AsiaNet/ -- EirGenix, Inc. announced today that it has entered into a license agreement with global generic and biosimilar drug manufacturer Sandoz AG, granting an exclusive license to Sandoz for right of commercialization of EirGenix 's breast cancer biosimi...
Authors: LATEST ASIANET NEWS RELEASES